1. Home
  2. CNXN vs AAPG Comparison

CNXN vs AAPG Comparison

Compare CNXN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PC Connection Inc.

CNXN

PC Connection Inc.

N/A

Current Price

$79.82

Market Cap

2.0B

ML Signal

N/A

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$17.20

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXN
AAPG
Founded
1982
2009
Country
United States
China
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
CNXN
AAPG
Price
$79.82
$17.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.40
AVG Volume (30 Days)
123.7K
5.1K
Earning Date
04-29-2026
05-20-2026
Dividend Yield
1.26%
N/A
EPS Growth
N/A
N/A
EPS
1.99
N/A
Revenue
N/A
N/A
Revenue This Year
$6.24
$290.34
Revenue Next Year
$4.39
N/A
P/E Ratio
$40.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.97
$16.36
52 Week High
$88.31
$41.72

Technical Indicators

Market Signals
Indicator
CNXN
AAPG
Relative Strength Index (RSI) 49.92 40.14
Support Level $76.20 N/A
Resistance Level $88.31 $18.17
Average True Range (ATR) 2.05 0.54
MACD -0.17 -0.06
Stochastic Oscillator 58.67 0.00

Price Performance

Historical Comparison
CNXN
AAPG

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: